| Split-thickness skin graft donor sites: a comparative study of two absorbent dressings. | |
| | |
MedLine Citation:
|
PMID: 18065019 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To identify the optimal dressing for split-thickness skin graft (SSG) donor sites. METHOD: This prospective randomised controlled trial compared two dressings - a new absorbent form of a polyurethane film dressing (Tegaderm Absorbent, 3M) and our standard alginate dressing (Kaltostat, ConvaTec) - on SSG donor sites in 40 patients. Primary outcome measures were: reduced time to full healing; reduced postoperative pain; reduced leakage rates from the dressing. Secondary outcome measures related to acceptability of the dressings to the patient. RESULTS: On removal of the dressings at the first assessment, 79% of the Tegaderm Absorbent donor sites had healed completely, compared with 16% of the Kaltostat ones (p<0.001).A significantly greater median area had healed with Tegaderm Absorbent (100%), when compared with Kaltostat (89%) (p<0.001). Mean time to complete healing was also significantly faster for Tegaderm Absorbent than Kaltostat (14 versus 21 days) (p<0.001). Significantly fewer subjects experienced postoperative pain with Tegaderm Absorbent on both day 1 (21% versus 67%, p=0.006, NNT=3) and day 2 (17% versus 75%, p<0.001, NNT=2). Leakage rates reduced by 48% with Tegaderm Absorbent, with no leakage in the smaller donor sites. Tegaderm Absorbent was significantly easier to apply than Kaltostat (89% versus 27% found it'very easy') as was ease of removal (84% versus 11% found it'very easy') (p<0.0001). Patients found Tegaderm Absorbent dressings significantly more convenient to manage and bathe with. At one month post-surgery, Vancouver scar scores showed thatTegaderm Absorbent donor sites were less red, flatter, softer and less itchy. CONCLUSION: Tegaderm Absorbent provides a significant improvement in terms of donor-site pain, healing and ease of management. |
| | |
Authors:
|
P J Terrill; R C W Goh; M J Bailey |
Related Documents
:
|
17620739 - Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wo... 1993229 - The treatment of donor sites with cultured epithelial grafts. 6751459 - The lateral paramedian incision--experience with 850 cases. 23547939 - Is tubeless pcnl really less injurious than standard in the mid-term? 9234109 - Wound healing: an endpoint for complex peripheral angioplasty. 23595509 - Mortality and major morbidity after tonsillectomy: etiologic factors and strategies for... 8087909 - Sugarless gum chewing before surgery does not increase gastric fluid volume or acidity. 19424749 - Is the retrojugular approach safer than the conventional approach for carotid endartere... 23063679 - Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of ... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of wound care Volume: 16 ISSN: 0969-0700 ISO Abbreviation: J Wound Care Publication Date: 2007 Nov |
Date Detail:
|
Created Date: 2007-12-10 Completed Date: 2008-02-01 Revised Date: 2009-11-03 |
Medline Journal Info:
|
Nlm Unique ID: 9417080 Medline TA: J Wound Care Country: England |
Other Details:
|
Languages: eng Pagination: 433-8 Citation Subset: N |
Affiliation:
|
Department of Surgery, Monash University, Melbourne, Australia. pjterril@bigpond.net.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Alginates / adverse effects, therapeutic use* Child Clinical Nursing Research Exudates and Transudates Female Glucuronic Acid / adverse effects, therapeutic use Hexuronic Acids / adverse effects, therapeutic use Humans Male Middle Aged Occlusive Dressings / adverse effects, standards* Patient Acceptance of Health Care Polyurethanes Postoperative Care / instrumentation, nursing Prospective Studies Skin Care / instrumentation*, nursing Skin Transplantation / adverse effects* Thigh / surgery Transplantation, Autologous / adverse effects Treatment Outcome Victoria Wound Healing* |
| Chemical | |
Reg. No./Substance:
|
0/Alginates; 0/Hexuronic Acids; 0/Polyurethanes; 576-37-4/Glucuronic Acid; 9005-32-7/alginic acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of ultrasound to characterise the fluid-handling characteristics of four foam dressings.
Next Document: Use of Dermabond tissue adhesive in hand surgery.